Company number 07696388
Status Active
Incorporation Date 7 July 2011
Company Type Private Limited Company
Address 2 HALL HOUSE, GUILDFORD ROAD LOXWOOD, BILLINGSHURST, WEST SUSSEX, RH14 0SA
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration eleven events have happened. The last three records are Confirmation statement made on 7 July 2016 with updates; Total exemption small company accounts made up to 31 July 2015; Annual return made up to 7 July 2015 with full list of shareholders
Statement of capital on 2015-07-07
GBP 10
. The most likely internet sites of PEMPHIMMUNE SOLUTIONS LIMITED are www.pemphimmunesolutions.co.uk, and www.pemphimmune-solutions.co.uk. The predicted number of employees is 1 to 10. The company’s age is fourteen years and five months. The distance to to Milford (Surrey) Rail Station is 7.9 miles; to Pulborough Rail Station is 8.1 miles; to Farncombe Rail Station is 9.2 miles; to Gomshall Rail Station is 10.6 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Pemphimmune Solutions Limited is a Private Limited Company.
The company registration number is 07696388. Pemphimmune Solutions Limited has been working since 07 July 2011.
The present status of the company is Active. The registered address of Pemphimmune Solutions Limited is 2 Hall House Guildford Road Loxwood Billingshurst West Sussex Rh14 0sa. The cash in hand is £12.28k. It is £-4.47k against last year. And the total assets are £12.3k, which is £-4.49k against last year. KILLEEN, Michael is a Director of the company. LANE, Jonathan Douglas is a Director of the company. The company operates in "Research and experimental development on biotechnology".
pemphimmune solutions Key Finiance
LIABILITIES
n/a
CASH
£12.28k
-27%
TOTAL ASSETS
£12.3k
-27%
All Financial Figures
Current Directors
Persons With Significant Control
Applisci Ltd
Notified on: 9 July 2016
Nature of control: Ownership of shares – More than 50% but less than 75%
Pharma Dev Enterprises
Notified on: 9 July 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%
PEMPHIMMUNE SOLUTIONS LIMITED Events
09 Jul 2016
Confirmation statement made on 7 July 2016 with updates
30 Jan 2016
Total exemption small company accounts made up to 31 July 2015
07 Jul 2015
Annual return made up to 7 July 2015 with full list of shareholders
Statement of capital on 2015-07-07
24 Apr 2015
Total exemption small company accounts made up to 31 July 2014
20 Sep 2014
Annual return made up to 7 July 2014 with full list of shareholders
Statement of capital on 2014-09-20
...
... and 1 more events
09 Aug 2013
Annual return made up to 7 July 2013 with full list of shareholders
Statement of capital on 2013-08-09
28 Feb 2013
Total exemption small company accounts made up to 31 July 2012
03 Aug 2012
Annual return made up to 7 July 2012 with full list of shareholders
03 Aug 2012
Appointment of Michael Killeen as a director
07 Jul 2011
Incorporation
-
MODEL ARTICLES ‐
Model articles adopted